Treatment of nonischemic dilated cardiomyopathy by intravenous infusions of the extracellular vesicle-enriched secretome of cardiovascular progenitor cells.

The MEARY Center is in charge of the manufacturing of SMART101, developed by Smart Immune, as part of two Phase I/II clinical trials.

These trials are evaluating the safety and efficacy of SMART101 in accelerating immune reconstitution to fight infection and relapse after allogeneic hematopoietic stem cell transplantation.

Umbilical cord-derived mesenchymal stromal cell therapy in SARS-CoV-2-associated acute respiratory distress syndrome (ARDS)

Treatment of severe refractory systemic lupus erythematosus by injection of allogeneic mesenchymal stem cells derived from the umbilical cord (EUDRACT N° 2017 001400 29)